flupenthixol has been researched along with Psychotic Disorders in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (51.61) | 18.7374 |
| 1990's | 3 (9.68) | 18.2507 |
| 2000's | 4 (12.90) | 29.6817 |
| 2010's | 6 (19.35) | 24.3611 |
| 2020's | 2 (6.45) | 2.80 |
| Authors | Studies |
|---|---|
| Elyasi, F; Heydari, F; Sadati, S | 1 |
| Barbui, C; Bertolini, F; Bovo, C; Correll, CU; Del Giovane, C; Gastaldon, C; Nosé, M; Ogheri, F; Ostuzzi, G; Papola, D; Purgato, M; Tedeschi, F; Turrini, G | 1 |
| Asmal, L; Chiliza, B; du Plessis, S; Emsley, R; Kilian, S; Phahladira, L | 1 |
| Asmal, L; Chiliza, B; du Plessis, S; Emsley, R; Kilian, S; Luckhoff, HK; Phahladira, L; Scheffler, F | 1 |
| Adams, CE; David, A; Mahapatra, J; Quraishi, SN; Sampson, S | 1 |
| Asmal, L; Chiliza, B; Emsley, R; Kilian, S; Phahladira, L | 1 |
| Asmal, L; Carr, J; Chiliza, B; du Plessis, S; Emsley, R; Kidd, M; Vink, M | 1 |
| Asmal, L; Carr, J; Chiliza, B; Dazzan, P; Emsley, R; Kidd, M; Kilian, S; Ojagbemi, A; Phahladira, L; Riaan Olivier, M; Scheffler, F | 1 |
| Bäumer, D; Ebert, D; Tebartz van Elst, L; Trimble, MR | 1 |
| Singh, AN | 1 |
| Parent, M; Toussaint, C | 2 |
| de Coninck, G; Denis, A | 1 |
| Balzamo, E; Lutrand, JC; Serbanescou, T | 1 |
| Assion, HJ; Heinemann, F | 1 |
| Collins, ED; Coomaraswammy, S; Evans, SM; Kleber, HD; Levin, FR; Regent, N | 1 |
| David, A; Quraishi, S | 1 |
| Haberfellner, EM | 1 |
| Al-Sughayir, MA | 1 |
| Blake, B | 1 |
| Freedman, R | 1 |
| Sieberns, S | 1 |
| Baudis, P; Dvoráková, M; Peterová, E; Vencovský, E | 1 |
| Haffmans, PJ; Hoencamp, E; Jansen, GS | 1 |
| Kehoe, R; Young, A | 1 |
| Balant-Gorgia, AE; Eisele, R; Garrone, G | 1 |
| Ardern, M; Gelder, MG; Jambor, K; Kolakowska, T; Mandelbrote, BM; Reveley, MA; Williams, AO | 1 |
| Ardern, M; Kolakowska, T; Williams, AO | 1 |
| Matheson, I; Skjaeraasen, J | 1 |
| Gottfries, CG; Green, L | 1 |
| Gottfries, CG | 1 |
3 review(s) available for flupenthixol and Psychotic Disorders
| Article | Year |
|---|---|
Maintenance Treatment With Long-Acting Injectable Antipsychotics for People With Nonaffective Psychoses: A Network Meta-Analysis.
Topics: Antipsychotic Agents; Aripiprazole; Clopenthixol; Delayed-Action Preparations; Flupenthixol; Fluphenazine; Haloperidol; Humans; Injections, Intramuscular; Network Meta-Analysis; Olanzapine; Paliperidone Palmitate; Patient Acceptance of Health Care; Phenothiazines; Psychotic Disorders; Risperidone; Schizophrenia; Secondary Prevention | 2021 |
Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders.
Topics: Antipsychotic Agents; Delayed-Action Preparations; Flupenthixol; Humans; Psychotic Disorders; Randomized Controlled Trials as Topic; Schizophrenia; Tranquilizing Agents | 2014 |
Depot flupenthixol decanoate for schizophrenia or other similar psychotic disorders.
Topics: Antipsychotic Agents; Delayed-Action Preparations; Flupenthixol; Humans; Psychotic Disorders; Schizophrenia; Tranquilizing Agents | 2000 |
4 trial(s) available for flupenthixol and Psychotic Disorders
| Article | Year |
|---|---|
Dorsal striatal volumes in never-treated patients with first-episode schizophrenia before and during acute treatment.
Topics: Adult; Antipsychotic Agents; Caudate Nucleus; Double-Blind Method; Female; Flupenthixol; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Organ Size; Psychiatric Status Rating Scales; Psychotic Disorders; Putamen; Risperidone; Schizophrenia; Schizophrenic Psychology; Software; Treatment Outcome; Young Adult | 2015 |
Flupenthixol versus haloperidol in acute psychosis.
Topics: Acute Disease; Adolescent; Adult; Aged; Anxiety Disorders; Bipolar Disorder; Female; Flupenthixol; Haloperidol; Humans; Male; Middle Aged; Paranoid Disorders; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Thioxanthenes | 1983 |
[Flupenthixol versus haloperidol in acute psychotic episodes].
Topics: Acute Disease; Adolescent; Adult; Aged; Bipolar Disorder; Double-Blind Method; Flupenthixol; Haloperidol; Humans; Middle Aged; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Thioxanthenes | 1982 |
Flupentixol and flupentixol decanoate, with special reference to their antipsychotic effect.
Topics: Adolescent; Adult; Aged; Body Weight; Clinical Trials as Topic; Decanoates; Flupenthixol; Humans; Injections; Mental Processes; Middle Aged; Psychotic Disorders; Schizophrenia; Thioxanthenes; Trifluoperazine | 1974 |
24 other study(ies) available for flupenthixol and Psychotic Disorders
| Article | Year |
|---|---|
The management challenges of a case with Flupentixol-induced neuroleptic malignant syndrome.
Topics: Antipsychotic Agents; Bromocriptine; Flupenthixol; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Psychotic Disorders | 2023 |
Brain volume changes over the first year of treatment in schizophrenia: relationships to antipsychotic treatment.
Topics: Adult; Antipsychotic Agents; Cerebral Cortex; Delayed-Action Preparations; Female; Flupenthixol; Gray Matter; Humans; Magnetic Resonance Imaging; Male; Psychotic Disorders; Schizophrenia; Treatment Outcome; White Matter; Young Adult | 2017 |
Changes in insight over the first 24 months of treatment in schizophrenia spectrum disorders.
Topics: Adolescent; Adult; Antipsychotic Agents; Cognition; Female; Flupenthixol; Health Personnel; Humans; Longitudinal Studies; Male; Psychiatric Status Rating Scales; Psychotic Disorders; Quality of Life; Schizophrenia; Schizophrenic Psychology; Time Factors; Treatment Outcome; Young Adult | 2019 |
Rate and predictors of non-response to first-line antipsychotic treatment in first-episode schizophrenia.
Topics: Adolescent; Adult; Age Factors; Antipsychotic Agents; Body Mass Index; Cohort Studies; Female; Flupenthixol; Humans; Longitudinal Studies; Male; Psychotic Disorders; Quality of Life; Schizophrenia; Treatment Outcome; Young Adult | 2015 |
Neurological soft signs in first-episode schizophrenia: State- and trait-related relationships to psychopathology, cognition and antipsychotic medication effects.
Topics: Antipsychotic Agents; Cognition; Female; Flupenthixol; Humans; Interview, Psychological; Linear Models; Longitudinal Studies; Male; Memory, Short-Term; Motor Activity; Neurologic Examination; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Treatment Outcome; Young Adult | 2017 |
Chronic antidopaminergic medication might affect amygdala structure in patients with schizophrenia.
Topics: Amygdala; Antipsychotic Agents; Brain; Clopenthixol; Dose-Response Relationship, Drug; Epilepsy, Temporal Lobe; Factor Analysis, Statistical; Flupenthixol; Haloperidol; Hippocampus; Humans; Psychotic Disorders; Risperidone; Schizophrenia; Trifluoperazine | 2004 |
Therapeutic efficacy of flupenthixol decanoate in schizoaffective disorder: a clinical evaluation.
Topics: Adult; Drug Evaluation; Female; Flupenthixol; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Psychotic Disorders; Thioxanthenes | 1984 |
The use of flupenthixol ('Fluanxol') in the management of behavioural disorders in disturbed and psychotic children.
Topics: Adolescent; Child; Child Behavior Disorders; Child, Preschool; Female; Flupenthixol; Humans; Male; Mental Disorders; Psychotic Disorders; Thioxanthenes | 1982 |
[Night sleep study in chronic psychotics under long term flupenthixol treatment (author's transl)].
Topics: Adult; Female; Flupenthixol; Humans; Male; Middle Aged; Psychotic Disorders; Sleep; Thioxanthenes; Time Factors | 1981 |
[Tardive dystonia. A rare neuroleptic-induced disease picture].
Topics: Basal Ganglia; Basal Ganglia Diseases; Drug Therapy, Combination; Dystonia; Electromyography; Female; Flupenthixol; Haloperidol; Humans; Magnetic Resonance Imaging; Middle Aged; Neurologic Examination; Psychotic Disorders; Torticollis | 1994 |
Flupenthixol treatment for cocaine abusers with schizophrenia: a pilot study.
Topics: Adult; Antipsychotic Agents; Cocaine-Related Disorders; Diagnosis, Dual (Psychiatry); Female; Flupenthixol; Humans; Male; Middle Aged; Neurologic Examination; Pilot Projects; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Substance Abuse Detection; Treatment Outcome | 1998 |
Remission of tardive dyskinesia after changing from flupenthixol to olanzapine.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Dopamine Antagonists; Dyskinesia, Drug-Induced; Flupenthixol; Humans; Male; Olanzapine; Pirenzepine; Psychotic Disorders; Remission Induction; Selective Serotonin Reuptake Inhibitors | 2000 |
Depot antipsychotics. Patient characteristics and prescribing pattern.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Clopenthixol; Delayed-Action Preparations; Drug Utilization; Female; Flupenthixol; Fluphenazine; Haloperidol; Hospitals, University; Humans; Male; Middle Aged; Practice Patterns, Physicians'; Psychotic Disorders; Saudi Arabia; Surveys and Questionnaires | 2000 |
Depot neuroleptics in a community mental health service.
Topics: Clopenthixol; Delayed-Action Preparations; Flupenthixol; Fluphenazine; Humans; Psychotic Disorders; Thioxanthenes | 1979 |
Interactions of antipsychotic drugs with norepinephrine and cerebellar neuronal circuitry: implications for the psychobiology of psychosis.
Topics: Action Potentials; Afferent Pathways; Animals; Cerebellum; Dose-Response Relationship, Drug; Drug Antagonism; Drug Interactions; Flupenthixol; Fluphenazine; Humans; Isomerism; Male; Models, Neurological; Neural Inhibition; Neurons; Norepinephrine; Promethazine; Psychotic Disorders; Purkinje Cells; Rats | 1977 |
[Studies on the long acting neuroleptic agent flupenthixol decanoate--a review (author's transl)].
Topics: Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Interactions; Dyskinesia, Drug-Induced; Flupenthixol; Humans; Psychotic Disorders; Schizophrenia; Thioxanthenes | 1978 |
[Clinical experiences with depot neuroleptics].
Topics: Delayed-Action Preparations; Depressive Disorder, Major; Female; Flupenthixol; Fluphenazine; Humans; Male; Psychotic Disorders; Schizophrenia; Thioxanthenes | 1975 |
Lowest effective dose of depot neuroleptics.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Flupenthixol; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology | 1992 |
Two cases of agranulocytosis on addition of a butyrophenone to a long-standing course of phenothiazine treatment.
Topics: Agranulocytosis; Antipsychotic Agents; Chlorpromazine; Clomipramine; Depressive Disorder; Dose-Response Relationship, Drug; Droperidol; Drug Therapy, Combination; Female; Flupenthixol; Fluphenazine; Humans; Long-Term Care; Male; Middle Aged; Paranoid Disorders; Psychotic Disorders | 1989 |
[Quantitative approach to treatment with incisive neuroleptics by therapeutic monitoring].
Topics: Adult; Antipsychotic Agents; Drug Interactions; Female; Flupenthixol; Haloperidol; Humans; Kinetics; Male; Middle Aged; Psychotic Disorders; Schizophrenia | 1985 |
Schizophrenia with good and poor outcome. I: Early clinical features, response to neuroleptics and signs of organic dysfunction.
Topics: Adult; Antiparkinson Agents; Antipsychotic Agents; Brain; Chlorpromazine; Cognition Disorders; Female; Flupenthixol; Fluphenazine; Humans; Male; Middle Aged; Prognosis; Prolactin; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Tomography, X-Ray Computed | 1985 |
Tardive dyskinesia and current dose of neuroleptic drugs.
Topics: Adult; Antipsychotic Agents; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Flupenthixol; Fluphenazine; Humans; Middle Aged; Psychotic Disorders; Schizophrenia | 1985 |
Milk concentrations of flupenthixol, nortriptyline and zuclopenthixol and between-breast differences in two patients.
Topics: Adult; Breast; Clopenthixol; Female; Flupenthixol; Humans; Hydrogen-Ion Concentration; Lactation; Milk, Human; Nortriptyline; Pregnancy; Psychotic Disorders; Puerperal Disorders; Thioxanthenes; Time Factors; Triglycerides | 1988 |
Flupenthixol decanoate--in treatment of out-patients.
Topics: Ambulatory Care; Female; Flupenthixol; Follow-Up Studies; Humans; Length of Stay; Male; Outpatient Clinics, Hospital; Paranoid Disorders; Psychotic Disorders; Recurrence; Schizophrenia; Thioxanthenes | 1974 |